在接受全身抗癌治疗的成年人中的脆弱性和结果:系统性审查和元分析
Jessica Pearce1,2, Sally Martin2, Sophie Heritage3
1Leeds Institute of Medical Research at St James', University of Leeds, Leeds, LS2 9JT, UK.
Journal of the National Cancer Institute
|January 31, 2025
概括
对癌症患者的脆弱性评估至关重要. 像G8和VES13这样的简短工具可以预测诸如生存和治疗耐受性等结果,帮助临床决策.
科学领域:
- 老年瘤学 老年瘤学
- 临床流行病学临床流行病学
- 癌症治疗结果的结果
背景情况:
- 脆弱性评估对于癌症治疗决策越来越重要.
- 本综述综合了关于脆弱性和全身抗癌治疗 (SACT) 结果的证据.
研究的目的:
- 评估在成人癌症患者的基线脆弱性和SACT结果之间的关联.
- 确定具有预后价值的验证的脆弱性评估工具.
主要方法:
- 系统地搜索5个数据库 (开始至2023年1月) 进行预后研究.
- 包括关于脆弱性和SACT结果的队列/病例控制研究.
- 关于脆弱性与生存,毒性,治疗耐受性和住院治疗之间的关联的元分析.
主要成果:
- 58项研究符合纳入标准;大多数具有偏差风险低/中等.
- 老年人-8 (G8) 和脆弱老年人调查-13 (VES13) 显示出预后价值.
- 脆弱性增加了死亡 (HR1.68),毒性 (OR1.83),治疗不耐受 (OR1.68) 和住院 (OR1.94) 的风险.
结论:
- 简短的脆弱性评估 (G8,VES13) 是SACT患者关键结果的预后.
- 这些工具的风险估计支持癌症护理的共享决策.
更多相关视频
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
16.3K
09:25The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
18.6K
相关概念视频
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
